Trial Information

Summary: Stop UC-Study for the Treatment of Pediatric Ulcerative Colitis.

Alfred I. DuPont Hospital for Children is currently recruiting subjects to participate in an experimental study for treating children with ulcerative colitis.

Study drug and procedures (including medical monitoring of your ulcerative colitis symptoms) will be made available to you at no cost. Compensation will be provided for your time and efforts in study participation as well as reimbursement for travel expenses.

To qualify, you must:

• Be between the ages of 5 and 17 years old.
• Have mild to moderate active ulcerative colitis symptoms (inflammation of the large intestine and rectum).

You will not qualify if you:

• Have severe ulcerative colitis,
• Are known to be intolerant or allergic to salicylates (e.g,: Bayer, Bufferin, Ecotrin),
• Have received immunosuppressant drugs (drugs to control autoimmune diseases) within 90 days before the study.

For more information,

If you would like to learn more about participating in this study, please send an e-mail message using the form below.